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Summary
Mycoplasma agalactiae, an important pathogen of
small ruminants, exhibits antigenic diversity by
switching the expression of multiple surface lipopro-
teinscalledVpmas(VariableproteinsofM. agalactiae).
Although phase variation has been shown to play
important roles in many host–pathogen interactions,
the biological signiﬁcance and the mechanism of
Vpma oscillations remain largely unclear. Here, we
demonstrate that all six Vpma proteins are expressed
in the type strain PG2 and all undergo phase variation
at an unusually high frequency. Furthermore, targeted
gene disruption of the xer1 gene encoding a putative
site-speciﬁc recombinase adjacent to the vpma locus
was accomplished via homologous recombination
using a replicon-based vector. Inactivation of xer1
abolished further Vpma switching and the ‘phase-
locked’mutants (PLMs) continued to steadily express
only a single Vpma product. Complementation of the
wild-type xer1 gene in PLMs restored Vpma phase
variation thereby proving that Xer1 is essential for
vpma inversions. The study is not only instrumental in
enhancing our ability to understand the role of Vpmas
in M. agalactiae infections but also provides useful
molecular approaches to study potential disease
factorsinother‘difficult-to-manipulate’mycoplasmas.
Introduction
Reversible high-frequency changes of bacterial cell sur-
faces via phase variation are thought to increase resis-
tance against host defences or enhance survival under
stressful environmental conditions (Henderson et al.,
1999; van der Woude and Baumler, 2004). Wall-less bac-
teria of the Mycoplasma genus include the smallest, self-
replicating prokaryotes and have lost many biosynthetic
pathways during their evolution which reﬂects their fastidi-
ous lifestyles. However, despite a reduced genome, many
species possess large multigene families devoted to
surface variation and are successful pathogens of immu-
nocompetent hosts (Citti et al., 2005). The presence of
such elaborate phase-variable systems in these minimal-
ist organisms highlights their signiﬁcance in pathogenesis
but their precise functions are rarely understood (Citti
et al., 1997; Denison et al., 2005).
The ruminant pathogen Mycoplasma agalactiae exhib-
its surface diversity through abundant and variable
expression of surface lipoproteins (Vpmas) encoded by a
multigene family (Glew et al., 2000). Although genetic
analysis has revealed the presence of six single-copy
vpma genes (vpmaU–Z) clustered in the type strain PG2,
the expression and variability of only two Vpma proteins,
namely VpmaU and VpmaY, have been established so far.
Sequence analyses showed that each mature Vpma is
composed of both unique and conserved amino acid
regions that can be shared between two or more vpma
gene products. (Glew et al., 2002). The 5′ untranslated
regions and those encoding the signal peptide are con-
served within the vpma gene family and share a high
identity to the equivalent regions of vsp genes forming a
similar multigene phase-variable system in the bovine
pathogen Mycoplasma bovis (Lysnyansky et al., 1999).
Both vsp and vpma genes contain repeated sequences,
exhibit the same lipoprotein cleavage motif (AAKC) and
encode similar short cytadherence epitopes (Glew et al.,
2002). Due to these similarities and the very close
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M. bovis (Askaa and Erno, 1976; Pettersson et al., 1996),
it is likely that the vpma and vsp loci were inherited from
a common ancestor. However, beyond the highly con-
served5′untranslatedandN-terminalregions,thevspand
vpmagenessharenosigniﬁcanthomologywitheachother
and their respective coding sequences being very different
from one another might have later evolved independently
as two separate systems to accommodate different host
speciﬁcities (Glew et al., 2000). Nevertheless, as both
these ruminant pathogens induce similar clinical signs
(mastitis, pneumoniae and arthritis) in their respective
hosts, it is speculated that the two homologous systems,
Vpmas and Vsps, might play similar roles during the
diseaseprocess(Glewet al.,2000).Comparedwiththe13
vspgenesdescribedinthevsplocusofM. bovistypestrain
PG45 (Lysnyansky et al., 1999), the vpma repertoire
describedinthetypestrainPG2ismuchsmallerandoffers
an opportunity to study the mechanism and pathogenicity
potential of such multigene antigenic variations. The
knowledgegainedthereofmightprovideimportantcluesto
understand M. bovis infections which cause major eco-
nomic losses worldwide (Nicholas and Ayling, 2003).
The Vpma and Vsp systems, as well as the Vsa system
of the murine pathogen Mycoplasma pulmonis, which also
belongs to the same Mycoplasma hominis phylogenetic
cluster (Pettersson et al., 2000), represent remarkable
examplesintermsofthemechanismgoverningtheirphase
variations. The mechanism governing Vpma, Vsp and Vsa
phase variations is thought to be driven by site-speciﬁc
DNA inversions which either link the ORF of a silent gene
to a unique active promoter, as observed in vpma and vsp
genes of M. agalactiae and M. bovis (Lysnyansky et al.,
2001;Glewet al.,2002;Flitman-Teneet al.,2003),respec-
tively, or juxtapose a DNA sequence containing the pro-
moter, ribosome binding site and ﬁrst 714 nucleotides of
the vsa coding region in front of the 3′ end of a previously
silent vsa gene in M. pulmonis (Bhugra et al., 1995; Shen
et al., 2000). Among mycoplasmas, another example
where phase variation in a lipoprotein gene family has
been described to be mediated by site-speciﬁc DNAinver-
sions is the P35 or Mpl family of Mycoplasma penetrans.
However, most of the 38 mpl genes are thought to be
independently switched ON↔OFF by DNA inversions
occurring in the adjacent invertible promoter sequences
and not by juxtaposition of a single promoter sequence
within the multigene locus (Horino et al., 2003). Another
difference is the distribution of the mpl gene clusters at
different chromosomal loci of M. penetrans, which is very
similar to the phase-variable systems of certain Bacteroi-
des species, where genes encoding capsular polysaccha-
rides and surface glycoproteins are not only distributed
throughout the chromosome, but are also similarly
switched ON↔OFF by promoter inversions brought about
by recombinases having a global action on several differ-
ent loci (Coyne et al., 2003; Fletcher et al., 2007; Roche-
Hakansson et al., 2007).
The presence of sequences resembling recombinase
genes, designated xer1, mbr and hvsR, showing high
homology to the members of the large protein family of
lambda integrases or tyrosine recombinases, has been
documented in the vicinity of the vpma, vsp and vsa loci
respectively (Glew et al., 2002; Ron et al., 2002). The
Xer1 and Mbr recombinase sequences and their pro-
posed recombination sites located in the 5′ untranslated
regions of the genes found in their respective multigene
loci share considerable homology (Glew et al., 2002; Ron
et al., 2002). On the other hand, HvsR shows less simi-
larity to Mbr and Xer1, and its known target sites show no
homology to the equivalent regions in the vsp and vpma
loci (Glew et al., 2002; Ron et al., 2002; Sitaraman et al.,
2002). Among these recombinases, HvsR is the only one
whose role in mediating site-speciﬁc rearrangements
has been experimentally demonstrated (Sitaraman et al.,
2002), whereas the role of Xer1 and Mbr in controlling
similar DNA inversions is predictive and has yet to be
proven.
Mycoplasma pulmonis also harbours a family of phase-
variable restriction and modiﬁcation enzymes encoded by
the variable hsd locus (Dybvig et al., 1998) that was
also found to undergo DNA rearrangements regulated by
HvsR. Interestingly, a similar hsd locus also exists in
M. agalactiae but includes an integrase like gene (int)
(Sirand-Pugnet et al., 2007). As M. pulmonis is phyloge-
netically related to M. agalactiae, the two phase-variable
systems might have evolved from a common ancestor,
leaving an intriguing possibility that vpma-speciﬁc recom-
binations might be controlled by the Int recombinase,
either completely, or in addition to the predicted Xer1
recombinase encoded in the vpma locus. In this given
scenario, the Xer1 recombinase, like HvsR, could also be
predicted to have dual substrate speciﬁcity recognizing
two distinct recombination sites, and catalyse DNA inver-
sions at both the vpma and hsd loci of M. agalactiae.
Another signiﬁcant feature of the vpma gene locus is
the presence of a homopolymeric tract of multiple thymi-
dine residues immediately upstream of the -10 region of
the unique vpma promoter (Flitman-Tene et al., 2003).
Such homo- or heteropolymeric tracts are known to
undergo frequent and reversible changes in the number of
nucleotides via slipped-strand mispairing and lead to
variation of cell surface proteins in many mycoplasma
species (Citti et al., 2005). For instance, the insertion or
deletion of nucleotides in the spacer region between the
-35 and -10 region has been shown to turn ON or OFF
the transcription of the vlp, maa2 and vmm genes of
Mycoplasma hyorhinis, Mycoplasma arthritidis and Myco-
plasma mycoides respectively (Citti and Wise, 1995;
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site-speciﬁc DNA recombination has been proposed as
the mechanism underlying Vpma phase variation (Glew
et al., 2002), slipped-strand mispairing might also be
operational in M. agalactiae and provide it with another
mode of eliciting surface diversity by turning ON or OFF
the single promoter present in the vpma locus.
The present work was undertaken to investigate the
nature of molecular switches involved in Vpma antigenic
variations, and to deﬁne the recombinase enzyme that
controls the expression and variability of all or some vpma
genes via site-speciﬁc DNA inversions within the vpma
multigene locus. One main impediment in this task was the
difficulty in isolating or distinguishing one Vpma variant
from another. Therefore, our objectives towards under-
standing the Vpma system were ﬁrst to develop speciﬁc
serological reagents to individually monitor the expression
and switching frequency of the six Vpma proteins of PG2,
and second to construct ‘phase-locked’mutants (PLMs) of
M. agalactiae that constitutively express only a single
Vpma protein. Even though the involvement of the int gene
(MAG5690) in regulating vpma inversions could not be
ruled out, we ﬁrst opted for disrupting the xer1 gene due to
its close proximity to the vpma locus that has been char-
acterized as a pathogenicity island-like locus (Glew et al.,
2002) and hence, is likely to carry its own recombinase
(Hacker et al., 1997). One strategy to inactivate the xer1
gene in M. agalactiae could be to use transposon
mutagenesis as done for inactivation of hvsR in M. pulmo-
nis (Sitaraman et al., 2002). However, in order to avoid the
possibility of mutant instability associated with transposon
mutagenesis, we established a disruption strategy based
on homologous recombination (HR). As targeted gene
disruptions via HR using classical ‘suicide vectors’ are a
very rare phenomenon in mycoplasmas (Dybvig and
Woodard, 1992; Dhandayuthapani et al., 1999; Markham
et al., 2003; Burgos et al., 2007), we decided to use an
M. agalactiae oriC plasmid (Chopra-Dewasthaly et al.,
2005a) to introduce a partial xer1 gene into PG2 to
increase the likelihood of a xer1 disruptive HR event. Such
oriCvectorshavebeensuccessfullyusedtoobtainspeciﬁc
gene disruptants in two mollicutes so far, Spiroplasma citri
(Duret et al., 1999) and Mycoplasma capricolum ssp.
capricolum (Janis et al., 2005).
In this study, disruption of xer1 is demonstrated to
abrogate subsequent DNA rearrangements within the
vpma locus and lead to the generation of PLMs proving
that xer1 is essential for Vpma antigenic switches in
M. agalactiae. Also, through the use of speciﬁc polyclonal
antibodies (pAbs) raised against all six Vpma proteins we
show that all six Vpmas are expressed within a population
of M. agalactiae type strain PG2, that this expression is on
the surface of the cells, and that all Vpmas exhibit an
unexpectedly high frequency of phase variation which
was underestimated in previous studies (Glew et al.,
2000). Comparative sequence analyses of the vpma loci
of the two PLMs with the published sequence of the clonal
variant 55-5 further supports the role of Xer1 in the
mechanisms of recombination.
Results
All six Vpma proteins are expressed in M. agalactiae
type strain PG2 and show a remarkably high frequency
of phase variation
In a previous study, expression and phase variation of only
two out of the six vpma genes encoded by the PG2 type
strain was demonstrated using monoclonal antibodies
(mAbs) or VpmaU and VpmaY rabbit antisera (Glew et al.,
2000; 2002). To further assess the expression proﬁles and
antigenic variation of the entire PG2 vpma locus,
sequences unique to each of the six vpma genes were
individually expressed as MBPfusion proteins and used to
raise Vpma-speciﬁc rabbit pAbs (Table 1, Fig. S1). These
antiseraidentiﬁeddistinctproductsinPG2whensubjected
toWesternblotanalysis(Fig. 1).ForallVpmaproteins,the
observed molecular weight was generally slightly higher
than that calculated from their respective sequences
(Table 1, Fig. 1).As shown for other mycoplasma proteins
(Bhugra et al., 1995), this might be due to the presence of
repetitive motifs in each Vpma. As expected, a-Y and a-U
pAbs recognized the same-sized antigens as identiﬁed by
the rabbit anti-VpmaY and anti-VpmaU sera obtained in
previous studies (Glew et al., 2000; 2002).
Table 1. Vpma MBP fusion proteins and the corresponding anti-Vpma polyclonal antibodies raised in rabbits.
Vpmas Primers
a Corresponding fusion proteins Corresponding pAbs Size of Vpmas (kDa)
b
VpmaU U2F/U2R FP-U a-U 23.2
VpmaV C1F/C1R FP-V a-V 35
VpmaW D1F/D1BR FP-W a-W 33.1
VpmaX X1F/X1R FP-X a-X 22.4
VpmaY Y3F/Y3R FP-Y a-Y 35.2
VpmaZ Z2F/Z1R FP-Z a-Z 34.2
a. Primers used for amplifying and cloning of unique regions for MBP fusion protein production (Table S1 and Fig. S1).
b. Calculated for the mature protein (without the signal peptide) based on the individual gene sequences determined for clone 55-5 that expressed
VpmaY (Glew et al., 2002).
1198 R. Chopra-Dewasthaly etal. 
© 2008 The Authors
Journal compilation © 2008 Blackwell Publishing Ltd, Molecular Microbiology, 67, 1196–1210Colony immunoblotting revealed positive, negative and
sectorial staining with all six anti-Vpma pAbs reﬂecting the
surface exposure, as well as the hypervariability of all
target epitopes in the PG2 strain (Fig. 2, row 1).
Targeted disruption of the xer1 gene via HR leads to the
isolation of Vpma PLMs
Construction of Vpma PLMs was undertaken to assess
whether the xer1 gene located adjacent to the vpma
locus controls Vpma phase variation by mediating vpma-
speciﬁc DNA recombination. As attempts to disrupt the
xer1 gene via HR using a suicide (non-replicative) vector
repeatedly failed, an alternate strategy was developed.
For this purpose, an internal portion of xer1 was cloned
into the replicative M. agalactiae oriC vector pMM21-7
that carries the tetM gene for tetracycline resistance (TetR)
(Chopra-Dewasthaly et al., 2005a). The resulting plasmid
pR3 was expected to replicate in PG2 thereby increasing
the occurrence of otherwise rare HR events. To enrich for
rare xer1 disruptions, the mixture of transformants was
passaged in selective media at least ﬁve times, followed
by two to ﬁve passages in non-selective media. The pres-
ence of xer1 disruptants in the transformed population
was assessed by a PCR assay designed speciﬁcally to
detect a 2.0 kb amplicon corresponding to pR3 integration
at the xer1 locus (Fig. S2). PCR-positive transformant
mixture passages were freshly grown and subjected to
colony immunoblot analyses using pAb a-U. If Xer1 was
the enzyme that indeed catalysed vpma gene inversions,
its disruption was anticipated to abrogate Vpma phase
variation and to result in a non-sectored phenotype when
immunostained with a particular anti-Vpma pAb. Conse-
quently, non-sectored VpmaU colonies were then picked
and screened again by PCR to detect xer1 disruption.
PCR-positive clones were then subjected to three succes-
sive rounds of colony puriﬁcation by colony immunoblot
staining and passaging in liquid medium to obtain a rig-
orously clonal culture expressing VpmaU referred to as
PLMU.As illustrated in Fig. 2 (row 2, column 1), the PLMU
mutant gave a homogenously positive colony staining
phenotype with pAb a-U and showed no negative or sec-
torial immunostaining. Further phenotypic veriﬁcation of
the selected PLMU clone was performed by subjecting
it to colony immunostaining with the other ﬁve Vpma-
speciﬁc antisera, namely a-V, a-Y, a-Z, a-X and a-W,
producing a negative phenotype (Fig. 2, row 2, columns
2–6) thereby proving the unavailability of the correspond-
ing epitopes on its cell surface.
Southern blot hybridization using a xer1-speciﬁc probe
demonstrated that the integration of plasmid pR3 did in
fact occur by HR at the chromosomal xer1 locus (Fig. 3).
Fig. 1. Western blot analyses of Triton X-114 phase material from
M. agalactiae type strain PG2 using pAbs a-U to a-Z (as described
in Table 1). Rabbit pAbs a-Vpma39 and a-Vpma34, previously
raised against denatured VpmaY and VpmaU epitopes (Glew et al.,
2000), respectively, served as positive controls. Protein size
standards are indicated in the left margin.
Fig. 2. Colony immunoblot analysis of
M. agalactiae type strain PG2 and its
derivative mutants using the six Vpma-speciﬁc
pAbs recognizing speciﬁc surface exposed
epitopes. PLMU and PLMY represent the two
xer1-disrupted PLMs expressing exclusively
VpmaU and VpmaY respectively. WT-PG2
and PLMU-CP representing the
xer1-complemented PLMU show sectorial
staining phenotype with all Vpma-speciﬁc
pAbs reﬂecting high frequency Vpma phase
variations. Designations of Vpma-speciﬁc
pAbs as used for each column, and as
described in Table 1, are indicated at the
bottom.
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M. agalactiae PG2 on a fragment of 13 kb (Glew et al.,
2002) (depicted as G in Fig. 3) and known to contain the
9.6 kb vpma locus (Glew et al., 2002; Sirand-Pugnet
et al., 2007) (Fig. 3A). As the disruption plasmid, pR3,
contains a unique ClaI site, plasmid integration via a
single HR event at the chromosomal xer1 locus was
expected to result in duplication of the partial xer1
sequence that would be segregated onto two ClaI frag-
ments (Fig. 3). As predicted, the 13 kb fragment is shown
to be absent in the xer1 disruptant (PLM), and instead,
displays two hybridization signals corresponding to (i) a
3.7 kb fragment carrying the plasmid oriC region and part
of the C-terminal coding region of xer1 (depicted as
DXERA in Fig. 3), and (ii) a 18.9 kb fragment carrying the
bla and tetM plasmid sequences, and the N-terminal
region of xer1, followed by the vpma genes (depicted as
DXERB in Fig. 3). The 10 kb fragment corresponding to
the linearized free replicating plasmid (P) was absent in
PG2 and in xer1-disrupted PLM (Fig. 3B).
Western blot analysis using whole-cell extracts of
PLMU conﬁrmed the results of colony immunoblot analy-
sis (Fig. 4). PLMU only reacted with pAb a-U, correspond-
ing to the VpmaU protein, and was not recognized by any
Fig. 3. Disruption of xer1 recombinase in M. agalactiae.
A. Schematic representation of the integration of disruption plasmid pR3 (P) into the genomic DNA of type strain PG2 to generate the PLMU
and PLMY clones. A 13 kb ClaI fragment of PG2 (G) consists of the known 9.6 kb vpma locus including the six vpma genes (white region) and
the complete xer1 gene (black shaded region). A single putative homologous recombination event between the partial xer1 sequence carried
by the plasmid pR3 and the chromosomal xer1 region is represented by crossed lines. This crossing over would lead to the integration of pR3
into the chromosome and would segregate the xer1 region onto two ClaI fragments DXERA and DXERB.
B. Southern blot hybridization showing the localization of pR3 at the chromosomal xer1 locus of M. agalactiae PG2. ClaI-digested DNA of xer1
disruptant (PLMU or PLMY) (lane 4), disruption plasmid pR3 (lane 3) and wt strain PG2 (lane 2) were probed with a xer1-speciﬁc DIG-labelled
fragment. l-HindIII DNA size marker (lane 1).
Fig. 4. Comparative Western blot analysis of
whole-cell extracts of M. agalactiae type strain
PG2 (WT-PG2), two PLMs (PLMY and PLMU)
and xer1-complemented PLMU (PLMU-CP)
using six different Vpma-speciﬁc pAbs as
described in Table 1. Designations of
individual pAbs used for each Western blot
are indicated in the right margins of each
panel whereas relevant protein size standards
are shown on the left margins.
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VpmaU upon 15 successive passages of PLMU, both in
the absence and presence of tetracycline selection, and
the complete lack of any spontaneous reversions or
vpma-speciﬁc rearrangements proved the ‘phase-locked’
VpmaU phenotype in this xer1 mutant (data not shown).
This was in contrast to the wt parental strain PG2 which
reacted with all six pAbs, and whose clonal variants
expressing VpmaU led to a mixed colony Vpma-staining
phenotype (positive, negative and sectorial) with almost
all pAbs within two to ﬁve in vitro passages, and as
well showed vpma-speciﬁc rearrangements observed by
Southern blot analysis (data not shown) indicating Vpma
phase variation.
To further conﬁrm the role of xer1 in Vpma phase varia-
tion, the same strategy was exploited to independently
obtain PLMY using pAb a-Y. This mutant showed a com-
pletely positive staining pattern with pAb a-Y and was
negative with all the other ﬁve antisera (Fig. 2, row 3).
Disruption of xer1 in PLMY was further conﬁrmed by
Southern blot analysis as described above. Like PLMU,
PLMY was phenotypically and genotypically stable even
after several in vitro passages (data not shown). Western
blot analysis using the whole-cell extracts of PLMY
(Fig. 4) supported the results of colony immunoblotting
(Fig. 2). PLMY showed a speciﬁc product of ~39 kDa with
pAb a-Y as expected and was negative with all other
pAbs, except with pAb a-Z which revealed a very faint
band corresponding to the presence of VpmaZ in this
mutant, although to a very low extent (Fig. 4). However,
no positive staining pattern was observed during colony
immunoblot analysis of PLMY using a-Z antisera, prob-
ably due to the very low expression level of VpmaZ.
Sequence analyses of the vpma gene loci of PLMU and
PLMY: gene organization and Rho-independent
terminator structures
In order to precisely deﬁne the conﬁguration of the vpma
loci in the PLMY and PLMU mutants, their ClaI-digested
genomic DNA were, respectively, self-ligated and used
to transform Escherichia coli DH10B. Tetracycline- and
ampicillin-resistant transformants were isolated and
subjected to restriction and PCR analyses (data not
shown). Two 18.9 kb recombinant plasmids, designated
as pPLMU and pPLMY, carrying the vpma loci (8.6 kb) of
PLMU and PLMY, respectively, were isolated for further
examination.
DNA sequencing of the pPLMY vpma locus revealed a
vpma gene organization similar to that found in the clone
55-5 (Fig. 5), which is known to express VpmaY (Glew
et al., 2002), and whose entire genome was recently
sequenced (Sirand-Pugnet et al., 2007). In pPLMY, as the
vpmaZ gene is located downstream of vpmaY and in the
same transcriptional orientation, a low level of ‘read-
through’ could explain the presence of VpmaZ as back-
ground expression in PLMY. In pPLMU, vpmaZ is placed
downstream of the transcribed vpmaU gene, but in the
opposite direction (Fig. 5) and thus, PLMU exhibits the
sole expression of VpmaU. In an earlier study of Glew
et al. (2002), Northern blot analyses indicated the pres-
ence of a single 1.6 kb vpmaY-mRNA in clone 55-5 and a
single 1 kb vpmaU-mRNA in clonal variant 55-7 that
expressed the VpmaU protein. The length of the detected
vpmaY transcript in 55-5 suggests the presence of a
termination structure immediately before the vpmaU
gene. Likewise, a termination structure must be present
shortly after vpmaU based on the data pertaining to 55-7.
Using the individual Vpma-speciﬁc pAbs, we could
detect a very low amount of VpmaZ protein in PLMY
corresponding to the vpmaY gene located downstream of
vpmaY thereby suggesting a transcriptional control of
termination. As mycoplasmas are known to lack the Rho
protein (de Hoon et al., 2005), we searched for putative
Rho-independent transcriptional terminators in the inter-
genic regions of the vpma loci that are characterized by
an inverted repeat followed by a stretch of thymidine
residues in the primary DNA sequence (Nudler and Got-
tesman, 2002; de Hoon et al., 2005). As described in
Experimental procedures, we used mathematical models
based on (i) the Gibbs free energy (-DG) of stem-loop
formation in the RNA and (ii) the properties of the thymi-
dine stretch in the primary DNAsequence (de Hoon et al.,
2005) to detect putative terminator structures in the vpma
locus (Table 2). In silico results indicated the presence of
such a structure 1560 bp downstream of the vpmaY tran-
scription start that is in perfect agreement with the mRNA
length detected by Northern blot analysis by Glew et al.
(2002). Similarly, a very strong termination structure was
detected just 40 bp downstream of the stop-codon of the
vpmaU gene and 970 bp downstream of the transcrip-
tional start of the vpmaU gene and correlates well with the
earlier mRNA studies (Glew et al., 2002) (Fig. 5, Table 2).
Further analysis of other vpma genes also revealed the
presence of Rho-independent terminator structures
between 40 and 80 nucleotides downstream of the
respective stop-codons (Fig. 5, Fig. S3). Although no ter-
minator was found immediately downstream of the xer1
gene, a strong termination signal was detected just down-
stream of the tRNA-lys (anti-CTT) gene suggesting the
bicistronic organization of these two genes (Fig. 5).
The sequences of PLMY and PLMU located between
the proposed recombination sites (RS, between position
-1t o-72 relative to the start codon of all vpma genes) are
identical to the published sequences of 55-5 (Glew et al.,
2002), even though some blocks were inverted as
expected (blocks A–E, Fig. 5). The 72 nucleotides of the
putative RS of each vpma gene (RSU–RSZ) differ maxi-
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regions between position -51 and -72 exhibit complete
sequence identity between all RS as also described by
Glew et al. (2002) for 55-5. Thus, recombination events
must occur in between the nucleotide position -72 and the
start codon of the respective vpma genes, otherwise the
sequences of blocksA–E (Fig. 5) would not be completely
identical in 55-5, PLMY and PLMU. Furthermore, the
recombination sites remain unaltered during different
vpma recombinatorial episodes as no nucleotide changes
were detected while comparing the sequences with the
published 55-5 sequence.
Complementation of the xer1 gene in PLMs restores
Vpma phase variation
In order to conﬁrm that xer1 expression is indeed essen-
tial to Vpma switching, a complete xer1 gene along with
its putative promoter was introduced into PLMY and
PLMU to restore phase variation. Initially, the entire xer1
gene along with its putative promoter was cloned in
Tn4001mod (Knudtson and Minion, 1993) and the result-
ant pR4 vector randomly inserted by transposition in the
genome of both PLMs. The same cloning sites of
Tn4001mod have been previously used in other myco-
plasma species for the successful expression of different
genes upon chromosomal integration (Hahn et al., 1996;
Fisseha et al., 1999; Dybvig et al., 2000; Liu et al., 2000;
Waldo and Krause, 2006). Although the presence of the
xer1 gene at different chromosomal loci of several
gentamicin-resistant (GentR) PLM clones was clearly
evident by PCR and Southern analysis (data not shown),
it failed to provide functional complementation in terms of
restoring Vpma phase variation.
As an alternative strategy, xer1 along with its putative
promoter was cloned in an oriC vector carrying the GentR
Fig. 5. Arrangement of the ORFs, terminator structures and inversions in the vpma loci of M. agalactiae type strain PG2 clonal variant 55-5,
PLMY and PLMU. Grey arrows represent the vpma genes, whereby a dark grey arrow denotes the vpma gene which is transcribed in the
respective clonal variant or PLM. The black arrows indicate the location of the unique promoter (P) in each vpma locus. Putative
recombination sites are indicated by white rectangles (RS) and denote sequences from -1t o-72 relative to the start codons of the
corresponding vpma genes. White arrows indicate ORFs other than vpma genes, like the intact xer1 recombinase (xer1) and a tRNA (tRNALYS)
gene in 55-5, whereas the discontinued white rectangles represent the promoter proximal regions of the disrupted xer1 genes (xer′)i nt h e
PLMs and a partial ORF (ORF′) in 55-5. A small grey rectangle indicates sequences derived from the integrated plasmid pR3. Non-translated
repeats of the vpmaY genes are indicated with a dotted-lined white arrow. Terminator structures are indicated with symbolized hairpins,
whereby Rho-independent terminator structures, for which experimental evidence is given, are drawn with a black-ﬁlled loop and are
white-ﬁlled otherwise. Sequence-identical blocks between PLMs and 55-5 are designated A to E and are indicated with INV when inverted
compared with 55-5. B, BamHI; E, EcoRI; H, HindIII; P, PstI; X, XbaI.
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plasmid p21-7Gxer (Fig. 6A), which was transformed into
the TetR mutants PLMU and PLMY. Interestingly, the
transformation frequency (TF) of p21-7Gxer in PLMs was
considerably low [4.3 ¥ 10-8 transformants per colony-
forming units (cfu)] compared with the other replicative
plasmid pR3 when transformed into PG2 (8 ¥ 10-6 trans-
formants per cfu). This implies that the introduction of a
Table 2. Characteristics of Rho-independent terminators of the vpma locus.
Hairpin
-DG
a
Stem
length
b
Loop
size
c
T-stretch
No. of Ts
T-stretch
score
d
Decision rule
d
e
Ter U 6.3 4 4 12 5.9 5.1
Ter V 13.7 10 5 8 4.8 2.3
Ter W 9.5 8 8 10 5.4 2.8
Ter X 7.5 9 6 11 5.8 3
Ter Y 5.8 7 3 9 5.3 1.7
Ter Z 6.3 6 8 11 5.8 3.1
Ter Xer 13.2 9 5 10 5.2 3.5
Mean 8.9 7.6 5.6 10.1 – –
Mycoplasma synoviae
e 8.4 7.7 5.1 10.7 – –
Escherichia coli
e 15.1 10.2 5.2 8.4 – –
Bacillus subtilis
e 14.9 9.1 5.2 9.3 – –
a. Gibbs free energy of stem-loop formation in kcal/mole at a temperature of 25°C.
b. Number of nucleotide pairs in the stem (see Fig. S3).
c. Number of nucleotides forming the loop structure (see Fig. S3).
d. Calculated according to de Hoon et al. (2005) (see Experimental procedures).
e. Mean values for predicted terminator structures in the genome of the respective bacteria according to de Hoon et al. (2005).
Fig. 6. Complementation of the wt xer1 gene
in PLMU.
A. Schematic representation of
complementation plasmid p21-7Gxer.
Restriction sites used for cloning purposes
are as indicated and arrowheads represent
direction of transcription; ColE1, E. coli origin
of replication; bla, ampicillin resistance gene;
aacA-aphD, Gent
R gene; oriC, M. agalactiae
origin of replication.
B. Southern blot analysis of
xer1-complemented PLMU. ClaI digest of
DNA from the complementation clone
PLMU-CP (lane 4) is shown in comparison
with wt strain PG2 (lane 1), PLMU (lane 2)
and complementation plasmid p21-7Gxer
(lane 3) after hybridization with a xer1-speciﬁc
DIG-labelled probe. G represents the 13 kb
ClaI fragment of M. agalactiae type strain
PG2 whereas DXERA and DXERB represent
the two ClaI fragments from PLMU (as
described in Fig. 3); PCP depicts the 9.5 kb
linearized complementation plasmid
p21-7Gxer. DNA size standards are indicated
in the left margin.
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to the cells. However, the TF of the complementation
plasmid p21-7Gxer into PG2 was also slightly lower
(3 ¥ 10-7) than pR3, and this might be a consequence of
xer1 overexpression. Also, the p21-7Gxer-complemented
PLM transformants sometimes displayed distorted colony
morphology upon initial selection on agar plates contain-
ing tetracycline and gentamicin. However, subsequent
growth and platings showed a normal phenotype without
any irregularities. The transformants were conﬁrmed by
PCR for the presence of the complete xer1 gene, the TetR
and GentR markers (data not shown). Selected positive
clones analysed in Southern hybridization using the xer1-
speciﬁc probe clearly demonstrated the presence of
plasmid p21-7Gxer as shown for the identically comple-
mented PLMU clone in Fig. 6B (lane 4). Besides the two
bands associated with the chromosomal xer1 disruption in
PLMs, the complemented clones depicted an additional
hybridization signal corresponding to the ~9.5 kb free p21-
7Gxer plasmid. Chromosomal integration of p21-7Gxer
was concluded to be absent as no additional hybridization
signals were observed in Southern blot analysis.
Having conﬁrmed the episomal presence of the comple-
mentationxer1gene copy, selected clones were subjected
to colony immunoblot analysis using the six Vpma-speciﬁc
pAbs to ascertain functional xer1 complementation in the
twoPLMs.InFig. 2(row4),thexer1-complementedPLMU
shows a mixed (positive, negative and sectorial) staining
pattern with all pAbs implying that it now exhibits variable
surface expression of all Vpma proteins in contrast to its
parent xer1-disrupted PLMU which shows a positive and
complete reaction only with the a-U antisera and no other
pAb. Similar results were obtained during Western blot
analysis where the xer1-complemented PLMU was shown
to express each of the six distinct Vpma proteins, similar to
the wt PG2 strain (Fig. 4). This is unlike its predecessor,
PLMU, which is recognized only with the a-U antiserum.
Similar genotypic and phenotypic analyses were also per-
formed with xer1-complemented PLMY (data not shown)
and the results conﬁrmed that Xer1 is also essential for
PLMYregaining Vpma phase variation. PLMs transformed
with the complementation plasmid lacking the xer1 gene
(control plasmid p21-7G) were not able to restore phase
variation and were phenotypically identical to the parent
xer1-disrupted PLMs.These data clearly demonstrate that
thepresenceofafunctionalXer1proteininbothPLMUand
PLMY initiates vpma-speciﬁc gene inversions that gener-
ate cell surface Vpma phase variation comparable to that
occurring in the wt PG2 strain.
Discussion
The study of phase variation and the mechanisms by
which it is elicited provides an insight into the processes
by which a pathogen is able to survive within varied and
complex host niches. Several genetic mechanisms of
pathogenic mycoplasmas have been described which
enable them to change their antigenic repertoire with
an unusually high frequency (Citti et al., 2005). Three
members of the M. hominis cluster, M. agalactiae,
M. bovis and M. pulmonis, have developed similar
mechanisms of mediating phase variation in their respec-
tive vpma, vsp and vsa gene families, where site-speciﬁc
DNArearrangements place alternative silent genes down-
stream of DNA sequences that contain single unique
promoters. M. penetrans, belonging to the Mycoplasma
pneumoniae cluster, also exhibits phase variation via site-
speciﬁc DNA inversions in the mpl multigene family that
consists of 38 genes. However, the expression of these
genes is proposed to be independently switched
ON↔OFF by adjacent invertible promoter sequences
(Horino et al., 2003). Two ORFs (MYPE8180 and
MYPE2900), located within the vicinity of the mpl genes,
have been suggested as candidates for mediating mpl
recombinatorial events (Horino et al., 2003). These
recombinases display signiﬁcant similarities with the Xer1,
Mbr and HvsR recombinases of the vpma, vsp and vsa
loci respectively (Chambaud et al., 2001; Ron et al., 2002;
Sirand-Pugnet et al., 2007). In the same phylogenetic M.
pneumoniae group, Ureaplasma parvum encodes three
recombinases (UU222, UU145 and UU529), whose func-
tions have not been proven, but are also closely related to
Xer1, Mbr and HvsR (Glass et al., 2000). Despite the
existing similarity between these recombinases, genes of
the respective phase-variable systems do not display any
homology to each other, except for the signal sequences
of vsp and vpma genes belonging to two closely related
Mycoplasma species. This might have been the result
of adaptive evolution, either to colonize different host
species or to perform different functions during the
disease process.
Although the Vpma, Vsp and Vsa antigenic variation
systems have been well studied at the DNA level, pheno-
typically, these proteins have only been observed using
immunoblot analysis employing mAbs that recognize
more than one member of the same multigene family. For
instance, mAb 7.1-2 recognizes all the proteins of the Vsa
family (Gumulak-Smith et al., 2001), whereas mAb 1E5
and mAb 3B3 recognize several proteins of the Vsp and
Vpma family respectively (Bergonier et al., 1996; Lysn-
yansky et al., 1999; Glew et al., 2000). The switching fre-
quencies calculated on the basis of results obtained with
such mAbs are expected to underestimate the rate of
variation of these proteins. The calculation of the switch-
ing frequency of variable proteins is based on the evalu-
ation of the progeny of a clonal variant which at ﬁrst
expresses only one distinct protein (Rosengarten and
Wise, 1990; Glew et al., 2002). The phenotype of the
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expression (+) or non-expression (-) of the respective
protein via colony immunoblots. By using pAbs speciﬁc to
each of the six individual Vpma proteins, the switching
frequency was observed to be much higher than the
earlier estimated frequency of 10-3 to 10-2 per cell
per generation based on the results obtained with
M. agalactiae-speciﬁc mAb 3B3 (Glew et al., 2000). In the
present study we show that mAb 3B3 also recognizes
VpmaX and VpmaW (Fig. S4), in addition to the already
reported VpmaY (Glew et al., 2000). Rather than express-
i n ga( +)o r( -) phenotype for a speciﬁc Vpma protein, a
vast majority of PG2 colonies exhibited a highly sectored
phenotype with these monospeciﬁc pAbs, and made it
impossible to denote a numerical value for Vpma switch-
ing frequency using standard methods. Extrapolating
these results to the parallel system of Vsp proteins in
M. bovis, it is likely that the Vsp switching frequency is
also much higher than the earlier reported frequency of
10-3 to 10-2 per cell per generation (Lysnyansky et al.,
1996).
In a recent study, the role of Vsa phase variations was
investigated in an animal experiment by PCR using the
M. pulmonis strain CT-AD as inoculum (Denison et al.,
2005). Although this study provided useful information
regarding the avoidance of the host immune system
through Vsa phase variation in M. pulmonis, similar
studies would be impossible using wt M. agalactiae
strains due to the extremely high frequency of Vpma
switching. Phase-variable lipoproteins are abundantly
expressed in mycoplasmas but their precise biological
signiﬁcance remains speculative. PLMs could serve as
important tools in comprehending the relevance of phase
variation of mycoplasma lipoprotein families during in vitro
and in vivo pathogenicity studies.
Disruption of the xer1 gene led to a Vpma ‘phase-
locked’ phenotype in M. agalactiae proving that Xer1
recombinase is indeed responsible for the site-speciﬁc
recombinations occurring within the vpma gene locus.
The results also demonstrate that the homopolymeric
T-tract found upstream of the unique vpma promoter does
not play any role in generating variation via slipped-strand
mispairing as none of the several independently screened
PLMY and PLMU colonies ever showed a negative phe-
notype where the respective VpmaY or VpmaU protein
was not expressed (data not shown).
In this study, we have described the presence of Rho-
independent terminator structures in the vpma locus and
have further strengthened the theory of the monocistronic
organization of the vpma genes. Nevertheless, the
hypothesis of a single Vpma protein being expressed
exclusively in all clones at all times does not seem to be
totally foolproof. The coexpression of VpmaZ in PLMY is
not surprising as the terminator of the vpmaY gene seems
to be the weakest terminator found in the vpma locus
(lowest d value) and the observed ‘read-through’ could be
a logical consequence of intermediate termination effi-
ciency (Table 2, Fig. 5 and Fig. S3).
In mycoplasmas, the organization of terminator struc-
tures has been proposed to be composed of weaker
stem-loop structures but very T-rich T-stretches (de Hoon
et al., 2005). The obtained values for the stem-loops and
the number of T’s in the T-stretch correlate nicely between
the terminators found in the vpma locus of M. agalactiae
and in the predicted terminators for Mycoplasma syn-
oviae, which represents the nearest related mycoplasma
species investigated by de Hoon et al. (2005) (Table 2,
Fig. S3).
Sequence analysis of the vpma loci of PLMY, PLMU
and clone 55-5 revealed that sequences most distant to
the xer1 gene remained completely unaltered (Fig. 5,
blocks D and E) whereas the xer1 proximal sequences
were rearranged (Fig. 5, blocks A–C). Although this might
be just a coincidence, it could, as well, be speculated that
the Xer1 recombinase functions preferentially in cis as
witnessed for certain transposases (Altenbuchner and
Schmitt, 1983; McFall, 1986; Adams et al., 2006), and this
would explain the observed predominance of VpmaU,
VpmaY and VpmaZ in the PG2 population (data not
shown). The failure of xer1 complementation by transpo-
sition may also support the hypothesis that Xer1 acts in a
cis-like fashion, with RS site preference inversely propor-
tional to the distance of the xer1 gene from its target RS
sequence.Attempts to restore phase variation in PLMs by
transposition, using a transposon containing a wt xer1
gene with its own putative promoter, were not successful,
even when analysed in many different mutants that rep-
resented insertions at different chromosomal loci. Thus,
the proximity of the xer1 gene to the vpma locus might be
an important factor for its functional activity. However, the
introduction of the xer1 gene via a multiple copy oriC
plasmid restored phase variation, which may be due to
the overproduction of the Xer1 protein that compensates
for the necessity of xer1 gene to be located adjacent to
the vpma locus.
Although complementation of the wt xer1 gene restored
phase variation, we cannot totally rule out the involvement
of other factors, including global regulatory proteins, in
controlling vpma gene inversions as observed in other
cases of bacterial phase variation involving gene inver-
sions (Henderson et al., 1999). It would be interesting to
know if Vpma phase variation events are random and
then selected by environmental factors, or are regulated
by the pathogen through other, as yet, unidentiﬁed factors
and regulators that might be operating only inside the
host. Taking into consideration the work by Sitaraman
et al. (2002) where HvsR was shown to control the vsa, as
well as the hsd phase-variable loci, it would be interesting
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any role in regulating the hsd locus in this species, espe-
cially as an integrase-like int gene (MAG5690) is present
within its hsd locus (Sirand-Pugnet et al., 2007).
This study demonstrates for the ﬁrst time that all six
vpma genes of the vpma multigene family are expressed
on the cell surface of variants comprising the
M. agalactiae type strain PG2. To our knowledge, this
has not been shown for all members of the vsa and
vsp multigene families of M. pulmonis and M. bovis,
respectively, which are close phylogenetic relatives of
M. agalactiae. For instance, in a study conducted by
Denison et al. (2005), 94% of the randomly checked
clones from the CT-AD strain of M. pulmonis were found
to express VsaG and 6% VsaH, whereas the other ﬁve
Vsa proteins were probably expressed, if at all, at levels
too low to be detected by the applied PCR analysis. The
anti-Vpma pAbs developed in this study will serve as
important reagents to speciﬁcally monitor the expression
of each individual Vpma product during future in vitro and
in vivo studies.Additionally, they could also help to assess
the potential of Vpmas to be used as serological tools for
early detection of infected animals. In general, myco-
plasma lipoproteins are strongly immunogenic in their
natural hosts and despite their intrinsic variability they are
known to induce an early and lasting humoral immune
response (Citti et al., 2005). Hence these Vpma-speciﬁc
antisera have the potential to be developed into efficient
disease markers for the control and eradication of
M. agalactiae infections.
To sum up, this study is a signiﬁcant step in myco-
plasma genetics as it describes the ﬁrst targeted gene
inactivation through HR in M. agalactiae and provides
novel insights into the mechanisms of antigenic variation
in M. agalactiae. Generation of PLMs offers a novel
concept in elucidating the role of mycoplasma phase-
variable lipoproteins in host–pathogen interactions.
Overall, the ﬁndings of this study are anticipated to
improve our understanding of the mechanisms which
enable mycoplasmas to cause chronic and difficult-to-
eradicate infections.
Experimental procedures
Bacterial strains and culture conditions
This study was carried out on M. agalactiae type strain PG2
(Solsona et al., 1996) grown at 37°C in modiﬁed Aluotto and
SP-4 medium supplemented with penicillin, pyruvate and
phenol red as described previously (Chopra-Dewasthaly
et al., 2005b). Mycoplasma transformants were selected
on SP-4 medium containing 1% Difco
TM Agar Noble and
2 mgm l
-1 tetracycline or/and 50 mgm l
-1 gentamicin as
appropriate. Cloning and ampliﬁcation of recombinant plas-
mids was carried out in E. coli DH10B (Invitrogen) grown at
37°C in standard Luria–Bertani medium (Sambrook et al.,
1989). The latter was supplemented with 50 mgm l
-1 ampicillin
and 10 mgm l
-1 tetracycline or 7 mgm l
-1 gentamicin as per
selection requirements.
Raising Vpma-speciﬁc pAbs
Rabbit antisera speciﬁc to the six Vpma proteins were raised
as follows. The unique and speciﬁc DNA sequences corre-
sponding to each of the six vpma genes were cloned in frame
to the malE gene in a pMAL
TM-c2 vector system to obtain the
respective MBP fusion proteins (see Table 1 and Table S1,
Fig. S1) according to the manufacturer’s instructions (New
England Biolabs). Protein expression was carried out in
E. coli TB1 (New England Biolabs) upon induction of the
lacZ promoter located upstream of the malE gene with
3 mM isopropyl-b-D-thiogalactopyranoside (IPTG). Whole-
cell extracts were sonicated and centrifuged and the cyto-
plasmic protein fractions were either puriﬁed via affinity
chromatography (for FP-U and FP-W) using an amylose
column, or loaded on an 8% non-denaturing polyacrylamide
gel (for FP-V, -Z, -X and -Y) to excise the appropriate bands
after electrophoresis and negative staining with zinc acetate
(negative staining kit, Bio-Rad). After destaining, the bands
were shredded into smaller pieces and frozen overnight
before lyophilization. The lyophilized proteins were
re-suspended in phosphate-buffered saline (PBS) and quan-
tiﬁed with the BCA kit (Pierce, Rockford, IL). About 100 mgo f
each puriﬁed protein was injected into two different New
Zealand White rabbits as described previously (Glew et al.,
2000). The resultant monospeciﬁc antisera were then analy-
sed in Western blots and colony immunoblots using type
strain PG2, clonal variant 55-5 (expressing Vpma Y; Glew
et al., 2000) and similar pBAD expressed His-tagged fusion
proteins of VpmaV, VpmaU, VpmaX and VpmaY. The latter
were made by excising the vpma-speciﬁc inserts from the
corresponding pMAL recombinant clones by EcoRI and
HindIII digestion and cloning them at the same sites of the
pBAD/His B vector (Invitrogen). The working dilutions for the
six rabbit pAbs were standardized against PG2 whole-cell
lysates in Western blots and colony immunoblots (a-U, 1:400;
a-V, 1:100; a-W, 1:600; a-X, 1:200–1800; a-Y, 1:500–2000;
a-Z, 1:100–600).
Colony immunoblot analysis
Protran
® nitrocellulose membranes (Schleicher and Schuell,
Germany) with a pore size of 0.2 mm were placed on freshly
grown mycoplasma colonies on the surface of agar plates for
about 3–5 min before detaching and drying them at room
temperature (RT). The membranes were rinsed two to three
times in TS buffer (10 mM Tris, 154 mM NaCl, pH 7.4) before
an overnight incubation at 4°C in Vpma-speciﬁc, appropri-
ately diluted antisera in TS buffer. Membranes were then
washed three times (for 10–15 min each) in TS buffer con-
taining 0.05% Tween
® 20 (Roth) and then incubated for a
minimum of 1 h at RT in 1:2000 dilution of swine anti-rabbit
IgG conjugated to horseradish peroxidase (DakoCytomation,
Denmark).After three washes (10 min each) in TS Buffer, the
colony blots were developed for 15–30 min in 4-chloro-1-
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stopped by washing the blots in water. Colony immunoblots
made with mAb 3B3 (1:300) (Bergonier et al., 1996) were
similarly developed after incubating with a goat anti-mouse
IgG (1:1000) procured from Jackson ImmunoResearch, USA.
All antibody dilutions were made in TS buffer and the blots
were agitated on a rocking platform during all incubation and
washing steps. The blots were then viewed and photo-
graphed using a Nikon SMZ-U stereomicroscope.
Western blotting
Vpma antigenic phenotypes were analysed by standard
sodium dodecylsulphate-polyacrylamide gel electrophoresis
(SDS-PAGE) using whole-cell extracts or Triton X-114
(Sigma) fractions as described elsewhere (Citti and Wise,
1995) in 10–12% polyacrylamide gels containing 3% (w/v)
urea. Samples were treated at 95°C for 5 min under reducing
conditions. Separated proteins were electrophoretically
transferred to Protran
® membranes using blotting buffer
(48 mM Tris, 39 mM Glycine, 0.037% SDS and 20% Metha-
nol) and immunostained by the same protocol as described
for colony immunoblots, except that when required sheep
anti-M. agalactiae serum (PAL) (Glew et al., 2000) was used
at a concentration of 1:200 and developed similarly after
incubation with rabbit anti-sheep IgG (1:2000) obtained from
DakoCytomation, Denmark.
DNA isolation, manipulation and Southern hybridization
Standard molecular biology procedures were used (Sam-
brook et al., 1989) except when stated otherwise. Plasmid
DNA was isolated from E. coli using E.Z.N.A.
® Plasmid
Miniprep Kit (Peqlab Biotechnologie GmbH). Mycoplasma
genomic DNA was isolated by QIAamp
® DNA Mini Kit
(Qiagen). Restriction endonucleases (Promega or New
England Biolabs) and T4 DNA ligase (Roche) were used
according to the manufacturers’ instructions. QIAquick
® PCR
Puriﬁcation and Gel Extraction Kits (Qiagen) were used for
routine DNA puriﬁcation during various cloning steps. South-
ern blot and hybridization techniques using DIG-labelling
system (Roche) have been described previously (Chopra-
Dewasthaly et al., 2005a) and were performed on ClaI-
digested DNA using a DIG-labelled probe corresponding to
the 513 bp partial xer1 PCR product (described below).
PCR ampliﬁcations
All DNA ampliﬁcations were carried out on a Perkin Elmer
GeneAmp thermal cycler using GoTaq
® Flexi DNA Poly-
merase (Promega) in 1¥ buffer supplied by the manufacturer
in the presence of 200 mM dNTPs and 1.4 mM of speciﬁc
primers.
The partial xer1 gene was ampliﬁed using XerR and XerS
primers with PG2 genomic DNA template in the presence of
2.5 mM MgCl2. An initial denaturation step of 7 min at 95°C
was followed by 30 cycles of 95°C for 43 s, 56°C for 43 s and
72°C for 43 s, and terminated with a 7 min cycle at 72°C to
yield a 513 bp amplicon.
Detection of xer1 disruption by integration of plasmid pR3
via HR at the chromosomal xer1 site was carried out in 25 ml
reactions using 2–4 ml of crude DNA extracts (Chopra-
Dewasthaly et al., 2005b), 2 mM MgCl2 and primers T3ISLrev
and RecendET28. Cycling parameters consisted of 1 cycle of
5 min at 94°C, 30 cycles of 1 min at 94°C, 1 min at 56°C and
2 min at 72°C and a concluding cycle of 5 min at 72°C. The
presence of a xer1 disruption event was identiﬁed by the
presence of a 2 kb product after PCR.
The 2.5 kb fragment containing the Gent
R determinant was
ampliﬁed from plasmid pISM2062 (Knudtson and Minion,
1993) using TnHind3 primer in the presence of 2 mM MgCl2.
The initial denaturation step was carried out for 5 min at
94°C, followed by 30 cycles of 1 min denaturation at 94°C,
1 min annealing at 63°C and 2 min 50 s extension at 72°C,
and a ﬁnal extension step of 7 min at 72°C.
The complete xer1 gene along with its putative promoter
(978 bp) was ampliﬁed using PG2 genomic DNA and primers
Xer1start_BamHI and Xer1stop_SmaI in the presence of
2.5 mM MgCl2. PCR cycling conditions consisted of an initial
denaturation for 5 min at 94°C, 30 cycles of 94°C for 1 min,
53.5°C for 1 min and 72°C for 1 min, followed by 7 min at
72°C.
Detection of Tet
R and Gent
R determinants in picked trans-
formants was carried out by PCR methods described previ-
ously (Chopra-Dewasthaly et al., 2005a,b) using primer pairs
TetF/TetR and Tn1/Tn2 respectively.
Construction of recombinant vectors
Plasmid pR2 (5.67 kb). The approximate 0.5 kb partial xer1
sequence was ampliﬁed (as described above) and digested
with KpnI/XbaI and cloned into the same sites of pUC18
(Invitrogen). The resulting plasmid construct was then
digested with HindIII and ligated to the 2.5 kb HindIII frag-
ment of pISM2062 (Knudtson and Minion, 1993) which con-
tains the Gent
R determinant for selection in mycoplasmas.
Plasmid pR3 (10 kb). pR2 was digested with HincII/EcoRI
and the partial xer1 fragment was excised and puriﬁed fol-
lowing agarose gel electrophoresis and then ligated to
SmaI/EcoRI-digested M. agalactiae oriC vector, pMM21-7
(Chopra-Dewasthaly et al., 2005a), to generate the replica-
tive plasmid pR3.
Plasmid pR4 (9.7 kb). The xer1 amplicon (as described in
the previous section) was digested with BamHI/SmaI and
cloned into the corresponding sites of Tn4001mod carried
by the vector pISM2062 (Knudtson and Minion, 1993). The
BamHI and SmaI sites in Tn4001mod are located within the
PIN promoter of the transposase gene in one IS element
resulting in an inactivated PIN promoter that cannot read
against a gene inserted in these cloning sites (Lyon et al.,
1984; Knudtson and Minion, 1993). The xer1 gene together
with its putative promoter was inserted such that the tran-
scription was directed outwards of the transposon. Thus, the
existing POUT promoter of the IS element will drive transcrip-
tion in the same direction as the putative xer1 promoter rather
than inhibiting transcription (Lyon et al., 1984; Waldo and
Krause, 2006). The nucleotide sequence of xer1 portion of
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duced during PCR ampliﬁcation and cloning.
Plasmid p21-7Gxer (9.5 kb). SacI-digested 6.013 kb frag-
ment of pMM21-7 was gel extracted and ligated to the
SacI-digested 2.5 kb fragment (carrying Gent
R determinant)
obtained by PCR. The resultant oriC plasmid p21-7G was
sequentially digested with BamHI/SmaI and ligated to the
BamHI/SmaI-digested 978 bp xer1 amplicon to produce p21-
7Gxer.
Transformation of M. agalactiae
Transformations were carried out essentially as earlier
described (Chopra-Dewasthaly et al., 2005b). Mid-log-phase
PG2 cells were electroporated with 2.5 mg of plasmid pR3 in
a 2 mm electrocuvette (at 2.5 V, 25 mF and 100 W) to obtain
xer1 disruption mutants. After an initial growth of 2 h in non-
selective SP-4 medium, 2 mgm l
-1 tetracycline was added and
cells were allowed to grow overnight. The transformation mix
was passaged daily by a 1:10 dilution into 1 ml of fresh SP-4
broth for 10–15 days, whereby the tetracycline concentration
was gradually increased from 2 to 10 mgm l
-1. From passage
5 onwards the cells were checked for the presence of xer1
disruption by PCR (explained above) and subjected to South-
ern blot hybridization. For complementation of the xer1 muta-
tion, PLMU was transformed with 2.5 mg of plasmid p21-
7Gxer and grown for 2 h in non-selective liquid medium
before adding 2 mgm l
-1 tetracycline and 50 mgm l
-1 gentami-
cin, followed by overnight incubation at 37°C and then plating
on selective SP-4 agar the next day.
Oligonucleotides and sequencing
DNA sequencing and the synthesis of all oligonucleotides
used in this study (Table S1) were carried out at VBC-Biotech
Services, Vienna. Sequences were analysed by advanced
BLASTX searches (Altschul et al., 1997) made at the website
for the National Center for Biotechnology Information (http://
www.ncbi.nlm.nih.gov/blast/blast.cgi) using the mold mito-
chondrial genetic code.
Prediction of Rho-independent terminator structures
Rho-independent terminator structures were predicted based
on the method of de Hoon et al. (2005). Brieﬂy, downstream
regions of the vpma genes were searched for T-stretches with
a minimum length of 14 nucleotides. Contrary to the method
of de Hoon et al. (2005), we required the T stretch to start with
at least four consecutive thymidine residues instead of two,
as mycoplasmas have a higher AT DNA content than the
bacteria dealt with by de Hoon et al. (2005). Calculation of
the RNA secondary structure and the Gibbs free energy of
formation for the terminator stem-loop structure were per-
formed with Mfold (Zuker, 2003) at a temperature of 25°C
as described (de Hoon et al., 2005).
The T-stretch score was evaluated as described by de
Hoon et al. (2005):
T
i
i
i =∗
−∗ ()
= ∑e
0 144
0
14
. δ
where di is one if the ith nucleotide is a thymidine and zero
otherwise.
The decision role d was calculated as described by de
Hoon et al. (2005):
d
G
n
T =∗
− [] ⎛
⎝
⎞
⎠ +∗ − 7 90 2 67 14 91 .. .
Δ kcal mole
SL
where DG is the Gibbs free energy of stem-loop formation in
kcal/mole at a temperature of 25°C, nSL is the number of
nucleotides in the entire stem-loop structure and T denotes
the T-stretch score described above. Values higher than zero
(discriminant line d = 0) indicate terminator structures and
higher d values correlate with stronger termination efficiency
(d’Aubenton Carafa et al., 1990; de Hoon et al., 2005).
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